Otoconin 90 Antibodies

Santa Cruz Biotechnology features a diverse variety of Otoconin 90 monoclonal antibodies for research focused on understanding inner ear development and function. Otoconin 90 Antibodies targeting Otoconin 90 perform exceptionally well in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Otoconin 90 is a key protein involved in the development and maintenance of the inner ear, playing a significant role in the formation of otoliths, which are essential for balance and spatial orientation. Research involving Otoconin 90 has revealed its importance in auditory and vestibular functions, making it a crucial target for studies related to hearing loss and balance disorders. Understanding Otoconin 90's role in otolith formation provides valuable insights into vestibular system development. Investigating Otoconin 90 expression patterns helps researchers better understand inner ear pathologies and potential therapeutic approaches. Current research utilizing Otoconin 90 monoclonal antibodies continues to uncover new aspects of inner ear biology and development. The high specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies targeting Otoconin 90 enable researchers worldwide to advance our understanding of hearing and balance disorders.